CDX-1401

· Celldex Therapeutics

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for CDX-1401, covering 2016-06-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 1]

See pricing